No. | Pathway | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | HN878 | CDC1551 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | Up / Down | Up / Down |
1 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES (41) | 23 | 22 | 0 | 0 | 6 | 0 | 0 | 1 | 22 | 0 | 23 | 0 | 0 | 17 / 6 | 11/12 |
2 | KEGG_CHEMOKINE_SIGNALING_PATHWAY (144) | 1 | 54 | 3 | 0 | 10 | 6 | 0 | 5 | 26 | 0 | 22 | 0 | 0 | 37 / 17 | 34 / 20 |
3 | REACTOME_INTERFERON_GAMMA_SIGNALING (40) | 0 | 0.1 | 26 | 5 | 3 | 5 | 4 | 0 | 0 | 0 | 0 | 5 | 1 | 21 / 5 | 15 / 11 |
4 | KEGG_GRAFT_VERSUS_HOST_DISEASE (21) | 0 | 0 | 0.3 | 15 | 2 | 8 | 3 | 0 | 3 | 0 | 0 | 14 | 3 | 15 / 0 | 7/8 |
5 | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY (80) | 0.3 | 0.3 | 0.1 | 0.1 | 29 | 7 | 0 | 0 | 8 | 2 | 6 | 2 | 2 | 27 / 2 | 17 / 12 |
6 | KEGG_LEISHMANIA_INFECTION (55) | 0 | 0.2 | 0.2 | 0.5 | 0.2 | 29 | 4 | 2 | 3 | 1 | 1 | 7 | 4 | 25 / 4 | 13 / 16 |
7 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_ | 0 | 0 | 0.2 | 0.2 | 0 | 0.2 | 23 | 6 | 0 | 2 | 1 | 3 | 3 | 21 / 2 | 17 / 6 |
 | BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL (36) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
8 | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_ | 0 | 0.1 | 0 | 0 | 0 | 0.1 | 0.3 | 37 | 2 | 6 | 2 | 0 | 3 | 23 / 14 | 27 / 10 |
 | VASCULAR_WALL (65) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
9 | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION (202) | 1 | 0.5 | 0 | 0.2 | 0.3 | 0.1 | 0 | 0.1 | 66 | 0 | 22 | 3 | 13 | 48 / 18 | 43 / 23 |
10 | PID_INTEGRIN1_PATHWAY (60) | 0 | 0 | 0 | 0 | 0.1 | 0 | 0.1 | 0.2 | 0 | 36 | 0 | 0 | 3 | 22 / 14 | 28 / 8 |
11 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS (121) | 1 | 0.5 | 0 | 0 | 0.2 | 0 | 0 | 0.1 | 0.5 | 0 | 44 | 0 | 0 | 28 / 16 | 22 / 22 |
12 | KEGG_ALLOGRAFT_REJECTION (25) | 0 | 0 | 0.3 | 0.9 | 0.1 | 0.5 | 0.2 | 0 | 0.2 | 0 | 0 | 15 | 3 | 14 / 1 | 8/7 |
13 | KEGG_HEMATOPOIETIC_CELL_LINEAGE (68) | 0 | 0 | 0 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | 0.1 | 0 | 0.2 | 34 | 24 / 10 | 25 / 9 |